You have no items in your cart.
Taysha, Catalent Partner to Advance Gene Therapies for Batten, Other Disorders
Batten Disease News
Taysha Gene Therapies announced that it has joined with Catalent, a pharmaceutical services provider, to support production of its potential gene therapies for disorders that include CLN1 Batten disease and Rett syndrome. ... Read more